Brain-Specific, Modular and Active RNA Therapeutics

B-SMART key facts

Countries involved


Belgium
Germany
Italy
Norway
Spain
The Netherlands
United Kingdom

Institutions involved


3
Universities
2
Research Institutes
4
Enterprises

Gender distribution


56%
Women
44%
Men

Further facts and figures


6.00 Mio €
B-SMART receives about 6.00 Mio € funding from the European Union’s Horizon 2020 Research and Innovation programme
NMBP-10-2016
B-SMART addresses the topic NMBP-10-2016: ‘Nanoformulation of biologicals’ of the European Union’s Horizon 2020 framework programme
9
B-SMART involves 9 partner institutions from seven different European countries
60
B-SMART has a duration of 60 months to achieve the objectives of the project

Download factsheet